Reply to: New Hope for Sarcopenia

J Am Geriatr Soc. 2018 Jan;66(1):208-209. doi: 10.1111/jgs.15187. Epub 2017 Nov 17.

Authors

Daniel Rooks^{1

2}, Ronenn Roubenoff^{1

2}

Affiliations

¹ Novartis Institutes for Biomedical Research, Cambridge, MA, USA.
² Novartis Institutes for Biomedical Research, Basel, Switzerland.

PMID: 29148045
DOI: 10.1111/jgs.15187

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Blocking
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Humans
Sarcopenia*

Substances

Antibodies, Blocking
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
bimagrumab